WHO’s Expanded Essential Drugs List Includes High-Priced Anticancers & Immunomodulators
Executive Summary
The World Health Organization has published its latest list of essential medicines, with a number of expensive drugs for cancers and autoimmune disorders figuring for the first time. The organization says that all patients should have access to life-saving medicines regardless of their ability to pay, but the pharmaceutical industry says this should be done with caution to avoid undermining innovation.
You may also be interested in...
Ambitious WHO Plan To Help 50 Nations Improve Regulatory Capacity
The World Health Organization has drawn up a plan to help member states build effective and efficient regulatory systems in order to deliver quality-assured medical products for all.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.